Recent searches
Search options
Administered by:
“In addition to the company’s $26,500 annual price tag for the drug, treatment could cost U.S. taxpayers $82,500 per patient per year, on average, for genetic tests and frequent brain scans, safety monitoring, and other care, according to estimates from the Institute for Clinical and Economic Review, or #ICER.” #dementia #alzheimer https://mastodon.social/@br00t4c/110844632735576774
Mastodonbr00t4c (@br00t4c@mastodon.social)New Alzheimer's drug will cost taxpayers billions, for limited effect
#allen #alzheimer
https://www.dailykos.com/stories/2023/8/6/2184859/-New-Alzheimer-s-drug-will-cost-taxpayers-billions-for-limited-effect